Polar Capital Global Healthcare Trust (LSE: PCGH), is a largeBritishinvestment trust focused on investments in the health sector. The company is listed on theLondon Stock Exchange and is a constituent of theFTSE 250 Index.[1]
The company was established as Polar Capital Global Healthcare Growth and Income Trust in May 2010 and adopted its current name in June 2017.[2] As of August 2025, its largest investments includedAstraZeneca,Eli Lilly and Company andUnitedHealth Group.[3]
In October 2025, the company asked investors to change the status of the trust from that with a limited term of eight years to one with an unlimited life, but with the opportunity for investors to exit the trust every five years.[4][5][6]
It is managed by Polar Capital and thechair is Lisa Arnold.[7]